AKOYA BIOSCIENCES INC. - COMMON STOCK

Akoya Biosciences Reports Third Quarter 2024 Financial Results

14 Nov 2024 15:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel

05 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

28 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

07 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

03 Oct 2024 15:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Reports Second Quarter 2024 Financial Results

05 Aug 2024 15:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

15 Jul 2024 15:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Reports First Quarter 2024 Financial Results

13 May 2024 15:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

09 May 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

06 May 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

02 May 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

22 Apr 2024 15:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

05 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

04 Mar 2024 15:05:00 By Nasdaq GlobeNewswire

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

08 Feb 2024 15:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

18 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

10 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook

07 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform

07 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow

07 Jan 2024 07:00:00 By Nasdaq GlobeNewswire